Shifting the Paradigm: A Population Health Approach to the Management of Direct Oral Anticoagulants

Author:

Allen Arthur L.1ORCID,Lucas Jessica2ORCID,Parra David34ORCID,Spoutz Patrick5ORCID,Kibert Jeffery L.6ORCID,Ragheb Bishoy7ORCID,Chia Linda3ORCID,Sipe Amy8ORCID

Affiliation:

1. Veterans Affairs Salt Lake City Health Care System Salt Lake City UT

2. North Florida/South Georgia Veterans Affairs Health Care System Gainesville FL

3. Pharmacy Benefits Management Veterans Integrated Service Network 8 Bay Pines FL

4. University of Minnesota College of Pharmacy Minneapolis MN

5. Pharmacy Benefits Management Veterans Integrated Service Network 20 Vancouver WA

6. Columbia Veterans Affairs Health Care System Columbia SC

7. Veterans Affairs Tennessee Valley Health System Murfreesboro TN

8. Academic Detailing Veterans Integrated Service Network 15 Kansas City MO

Abstract

Abstract Over the past decade, direct oral anticoagulants (DOACs) have contributed to a major paradigm shift in thrombosis management, replacing vitamin K antagonists as the most commonly prescribed anticoagulants in many countries. While DOACs provide distinct advantages over warfarin (eg, convenience, simplicity, and safety), they are frequently associated with inappropriate prescribing and adverse events. These events have prompted regulatory agencies to mandate oversight, which individual institutions may find difficult to comply with given limited resources. Veterans Health Administration (VHA) has leveraged technology to develop the DOAC Population Management Tool (PMT) to address these challenges. This tool has empowered VHA to update a 60‐year standard of care from one‐to‐one provider‐to‐patient anticoagulation monitoring to a population‐based management approach. The DOAC PMT allows for the oversight of all patients prescribed DOACs and leads to intervention only when clinically indicated. Using the DOAC PMT, facilities across VHA have maximized DOAC oversight while minimizing resource usage. Herein, we discuss how the DOAC PMT was conceived, developed, and implemented, along with the challenges encountered throughout the process. Additionally, we share the impact of the DOAC PMT across VHA, and the potential of this approach beyond anticoagulation and VHA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014

2. National Patient Safety Goals. The Joint Commission; 2019. Available at: https://www.jointcommission.org/standards/national‐patient‐safety‐goals/. Accessed August 7, 2020.

3. Sentinel Event Alert 61 Managing the risks of direct oral anticoagulants. The Joint Commission; 2019. Jointcommission.Org. Available at: https://www.jointcommission.org/resources/patient‐safety‐topics/sentinel‐event/sentinel‐event‐alert‐newsletters/sentinel‐event‐alert‐61‐managing‐the‐risks‐of‐direct‐oral‐anticoagulants/. Accessed August 7, 2020.

4. Planning, O. O. P. A. VA.gov | Veterans Affairs. National Center for Veterans Analysis and Statistics; 2019. Available at: https://www.va.gov/vetdata/.Accessed August 7, 2020.

5. Working smarter, not harder: evaluating a population health approach to anticoagulation therapy management

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3